iSOFT collaborates with Intel and Motion Computing on launch of Mobile Clinical Assistant

iSOFTFollowing months of development and collaboration, iSOFT has announced its intention to support its customers in their adoption of the Mobile Clinical Assistant (MCA). The platform, announced earlier by Intel Corporation and Motion Computing, will allow clinicians to spend more time with patients, help improve patient safety and reduce medication administration errors. Motion Computing's C5 is the first product based on Intel's platform and has earned support from clinicians and nurses participating in pilot studies conducted around the world.

In the UK trial at Salford Royal NHS Foundation Trust, phlebotomists and nurses used iSOFT's i.Clinical Manager (i.CM) on MCA devices. The project at Salford Royal was primarily to understand precisely how the MCA would be used in practice by clinical staff when it is integrated with actual medical and business processes.

Fifteen MCAs loaded with iSOFT's i.CM were used in a trial at Salford Royal. The ability to view and record clinical details at the point of care was found to improve the quality of information and efficiency of clinicians. Access to information in real-time proved particularly beneficial to phlebotomists as it prevented blood samples being taken unnecessarily and the need for duplicate tests. Salford Royal is an existing user of iSOFT's i.CM clinical software application as well as other iSOFT applications for patient administration, accident and emergency, and laboratory information systems.

"As a leading EMR provider, iSOFT is a natural choice for MCA trial collaboration," said Louis Burns, vice president and general manager, Intel's Digital Health Group. "We have enjoyed working closely with iSOFT, Motion, the NHS and the nurses at Salford Royal to develop a technology solution that truly serves the needs of healthcare professionals in clinical settings."

"Historically, one of the reasons EMR implementations have been only moderately successful is that independent vendors of hardware, software and infrastructure did not collaborate early enough in the solution design lifecycle," said Nigel Owens, Motion general manager of EMEA. "That's why iSOFT's work here is important. Its work with Motion and Intel will continue to help improve clinician experiences with the Motion C5 MCA."

Bill Henry, iSOFT's chief operating officer, said: "MCA is a major advance in mobile healthcare computing and finally puts computer technology into care environments safely. Having real-time clinical information to support decisions at the point of care while also minimising the risk of infection, is a huge benefit to clinical staff and patients alike. To improve the quality of healthcare and staff workflow, it is vital to have accurate and up-to-date information at the point of decision, whether on a ward or in a surgical department.

"Our collaboration with Intel and Motion, in the only clinician usability and field trial within the NHS using the Motion C5 MCA, is a testament to our standing as a world-class provider of clinical applications such as i.CM."

Henry added: "This technology offers significant opportunities for iSOFT and its customers and we will continue to work with Intel and Motion in helping to develop this set of products. We remain committed to supporting our customers in the delivery of better healthcare through the combination of our leading software and technology from partners such as Motion and Intel."

iSOFT has a long-standing commitment to mobile technology. The company was selected as Microsoft's exclusive European software partner for the launch of its tablet PC in 2002.

Related news articles:

iSOFT is Europe's largest healthcare software applications company and also has a strong presence and experience in the Asia Pacific region. Its core strategic application, LORENZO, is at the forefront of the technology revolution taking place in healthcare globally. iSOFT products are used to manage patient information in more than 8,000 organisations in 27 countries. With annual revenues of £180 million, the company has offices in 12 countries and more than 3,000 employees, over 1,400 of whom are engaged in software development and design. Further information: http://www.isoftplc.com.

Most Popular Now

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...